NIH-funded research NIH-funded research

Understanding and targeting pain and progression in knee osteoarthritis

Official title: BCCMA: Targeting Osteoarthritis Pain and Progression: Defining biologic and inflammatory markers associated with rapid progression

Funded at Veterans Admin Palo Alto Health Care Sys · NIH-11044086 · Data updated 2026-11-12

This study is looking at how certain biological markers relate to knee pain and the worsening of osteoarthritis, especially in younger veterans, to help find better treatments that can ease pain and slow down joint damage.

More Osteoarthritis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Admin Palo Alto Health Care Sys
NIH-funded
Lab location1 site (Palo Alto, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2026
Funding year2025
NIH project number5I01CX002527-03
Project IDNIH-11044086 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are veterans experiencing knee osteoarthritis symptoms without significant radiographic signs of the disease.

Less likely to help

Patients with advanced knee osteoarthritis showing significant radiographic changes may not benefit from this research.

What this research studies

This research investigates the biological and inflammatory markers associated with knee osteoarthritis (OA) pain and progression, particularly in veterans who experience OA at younger ages. The study aims to identify the immune responses that contribute to the variability in OA symptoms and structural changes in the joints. By analyzing both clinical data from patients and animal models, the research seeks to develop targeted treatments that can alleviate pain and slow down the progression of OA before significant joint damage occurs.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively reduce pain and prevent the progression of knee osteoarthritis.

How similar studies have gone: Previous research has shown promise in targeting immune responses in osteoarthritis, suggesting that this approach could yield significant advancements in treatment.

Where this research is happening

  • Veterans Admin Palo Alto Health Care Sys
    Palo Alto, United States
    Active

Researchers

  • Principal investigator: Chu, Constance R — Veterans Admin Palo Alto Health Care Sys
  • Study coordinator: Chu, Constance R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.